![Sérgio Paulo de Magalhães Simões](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sérgio Paulo de Magalhães Simões
Amministratore Delegato presso Luzitin SA
Profilo
Sérgio Paulo de Magalhães Simões is the founder and Chairman of Treat U SA, a company founded in 2010.
He is currently the Executive Chairman & Chief Executive Officer of Luzitin SA, Director of Biocant Ventures SA since 2012, and Director, VP-Business & Product Development of Bluepharma Indústria Farmacêutica SA since 2013.
Dr. de Magalhães Simões previously worked as an Assistant Professor at the University of Coimbra.
He holds graduate and doctorate degrees from the University of Coimbra.
Posizioni attive di Sérgio Paulo de Magalhães Simões
Società | Posizione | Inizio |
---|---|---|
Luzitin SA
![]() Luzitin SA Pharmaceuticals: MajorHealth Technology Luzitin SA provides photodynamic therapy and photodiagnosis solutions. The firm develops new compounds to improve the efficiency of photodynamic therapy in the treatment of cancer. The company was founded by Luís Arnaut in 2010 and is headquartered in Coimbra, Portugal. | Amministratore Delegato | - |
Bluepharma Indústria Farmacêutica SA
![]() Bluepharma Indústria Farmacêutica SA Pharmaceuticals: MajorHealth Technology Bluepharma Indústria Farmacêutica SA develops, manufactures, and markets pharmaceutical drugs The firm operates through the following business areas: Production of Pharmaceutical Drugs for Bluepharma and Other Companies; Research, Development, and Registration of Pharmaceutical Drugs; and Marketing of Generic Pharmaceutical Drugs. Its services include licensing, contract manufacturing, product development, and research and development. The company was founded in February 2001 and is headquartered in Coimbra, Portugal. | Direttore/Membro del Consiglio | - |
Biocant Ventures SA
![]() Biocant Ventures SA Investment ManagersFinance Biocant Ventures SA (Biocant) is an Independent Venture Capital firm founded in 2006. The firm is headquartered in Cantanhede. | Direttore/Membro del Consiglio | 01/01/2012 |
Treat U SA
![]() Treat U SA BiotechnologyHealth Technology Treat U SA develops targeted nanotechnology-based platforms for the specific delivery of drugs in the oncology area. It offers PEGASEMP, a platform conceived for delivering a cytostatic agent specifically to the tumor microenvironment, targeting two distinct cell populations: the cancer cell and the endothelial cells from the tumor blood vessels. The firm operates through its offices in Cantanhede and Coimbra. The company was founded in January 2010 by Vera Moura and Sérgio Paulo de Magalhães Simões and is headquartered in Coimbra, Portugal. | Fondatore | 01/01/2010 |
Precedenti posizioni note di Sérgio Paulo de Magalhães Simões
Società | Posizione | Fine |
---|---|---|
University of Coimbra | Corporate Officer/Principal | - |
Formazione di Sérgio Paulo de Magalhães Simões
University of Coimbra | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Biocant Ventures SA
![]() Biocant Ventures SA Investment ManagersFinance Biocant Ventures SA (Biocant) is an Independent Venture Capital firm founded in 2006. The firm is headquartered in Cantanhede. | Finance |
Bluepharma Indústria Farmacêutica SA
![]() Bluepharma Indústria Farmacêutica SA Pharmaceuticals: MajorHealth Technology Bluepharma Indústria Farmacêutica SA develops, manufactures, and markets pharmaceutical drugs The firm operates through the following business areas: Production of Pharmaceutical Drugs for Bluepharma and Other Companies; Research, Development, and Registration of Pharmaceutical Drugs; and Marketing of Generic Pharmaceutical Drugs. Its services include licensing, contract manufacturing, product development, and research and development. The company was founded in February 2001 and is headquartered in Coimbra, Portugal. | Health Technology |
Luzitin SA
![]() Luzitin SA Pharmaceuticals: MajorHealth Technology Luzitin SA provides photodynamic therapy and photodiagnosis solutions. The firm develops new compounds to improve the efficiency of photodynamic therapy in the treatment of cancer. The company was founded by Luís Arnaut in 2010 and is headquartered in Coimbra, Portugal. | Health Technology |
Treat U SA
![]() Treat U SA BiotechnologyHealth Technology Treat U SA develops targeted nanotechnology-based platforms for the specific delivery of drugs in the oncology area. It offers PEGASEMP, a platform conceived for delivering a cytostatic agent specifically to the tumor microenvironment, targeting two distinct cell populations: the cancer cell and the endothelial cells from the tumor blood vessels. The firm operates through its offices in Cantanhede and Coimbra. The company was founded in January 2010 by Vera Moura and Sérgio Paulo de Magalhães Simões and is headquartered in Coimbra, Portugal. | Health Technology |
- Borsa valori
- Insiders
- Sérgio Paulo de Magalhães Simões